Delivery Order SPE2DB20D1100-SPE2DB24FD1P8
Award Date
8/7/24
Potential Completion Date
8/28/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,105.45, is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the information provided. AmerisourceBergen Drug...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,526.54 and is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,242.60 firm fixed price delivery order is for the supply of HEMANGEOL 4.28 MG/ML oral solution in 120 mL units, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract, valued at $2,485.20, is a firm fixed-price delivery order with a completion date of May 7, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a potential value of $1,242.60 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award. The contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has a ceiling value of $1,656.80 and an ultimate completion date of September 3, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,656.80 firm fixed-price contract is for the delivery of 120 milliliters of HEMANGEOL 4.28 mg/ml oral solution, a specialty medication. The contract has an ultimate completion date of October 7, 2024 and was awarded on September 16, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,656.80, is a firm fixed-price delivery order issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently...
The Defense Logistics Agency awarded a $2,196.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120ml bottles of 4.28mg/ml oral solution of HEMANGEOL under contract number 4562076621. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania for use by the Department of Defense between September 5th and 26th, 2023. The delivery order was awarded against the Defense...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,656.80 firm fixed price contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has a completion date of May 8, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract...